Home » ASH ACCESS TECHNOLOGY PARTNERS WITH DAVITA CLINICAL RESEARCH TO CONDUCT PIVOTAL FDA CLINICAL TRIAL
ASH ACCESS TECHNOLOGY PARTNERS WITH DAVITA CLINICAL RESEARCH TO CONDUCT PIVOTAL FDA CLINICAL TRIAL
Ash Access Technology, Inc., a privately held biomedical and medical device
company in Lafayette, Indiana, announced today that it has established an agreement
with DaVita Clinical Research (a subsidiary of DaVita Inc.) to conduct the pivotal
Food & Drug Administration clinical trial for its flagship antimicrobial/antithrombotic
therapy in select dialysis clinics across the United States.
MarketWire
KEYWORDS FDAnews Device Daily Bulletin
Upcoming Events
-
25Apr
-
07May
-
14May
-
30May